Orphazyme's IPO

Orphazyme raised a round of funding on November 16, 2017. Investors include Public.

Orphazyme develops new therapies for the treatment of rare and genetic diseases. The company is founded on the pioneering research from the laboratory of Professor Marja Jaattela, and with the aim of …

Articles about Orphazyme's IPO: